The AI drug discovery founder makes the claim while thanking Andrew Adams for the ARDD2026 aging research conference.
Recap by typeshit. Post by Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs) on X.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
The longevity researcher links out to a longer look at what GLP-1 drugs may offer, where the risks lie, and the microdosing trend.
Two ASPS member surgeons walk through the breast changes patients may notice after losing weight on GLP-1 drugs, and what to know about them.
Loading…